Zynerba Pharmaceuticals Inc ZYNE shares are trading higher by $1.07 at $13.18 in Tuesday's session. Despite a Q3 EPS miss of 4 cents, the stock is trading in the green.
After a lower open, Zynerba immediately found support at $11.40 and began to move higher. That low coincides with Friday's low of $11.30. As of 3:06 p.m. EST, the ensuing rally found resistance just above Monday's high ($13.66), reaching $13.74. In order to fill the void price from its August 4 session, it will need to reach $13.83.
On the following day, the stock swooned to $6.67 from its $15.06 close following a disappointing Phase 2 trial of ZYN002 for treatment of adult epileptic patients with focal seizures.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.